Nasobol Inhalo, Brausetabletten zur Herstellung eines Dampfs zur Inhalation

7680557370141 CH-55737 Brausetabletten
Nasobol Inhalo, Brausetabletten zur Herstellung eines Dampfs zur Inhalation
Nasobol Inhalo, Brausetabletten zur Herstellung eines Dampfs zur Inhalation
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
30
Selling units
30
Measure
Tablette(n)
Galenic form
Brausetabletten
Galenic group
Brausetabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
19/02/2026
Summary of Product Characteristics
Français
19/02/2026
Summary of Product Characteristics
Italien
19/02/2026
Patient information leaflet
Allemand
17/02/2026
Patient information leaflet
Français
17/02/2026
Patient information leaflet
Italien
17/02/2026

Detailed composition

Substance Quantity Type Category
cineolum
9.1 MG Substance Wirkstoff (Principe actif)
levomentholum
9.2 MG Substance Wirkstoff (Principe actif)
rosmarini aetheroleum
8.5 MG Substance Wirkstoff (Principe actif)
thymi aetheroleum
4.2 MG Substance Wirkstoff (Principe actif)
lavandulae aetheroleum
- Substance HNIDK
sorbitolum
- Substance HNIDK
maltodextrinum
- Substance HNIDK
acidum citricum
- Substance HNIDK
calcii carbonas
- Substance HNIDK
mannitolum
- Substance HNIDK
magnesii subcarbonas ponderosus
- Substance HNIDK
talcum
- Substance HNIDK
aromatica
- Substance AROMA
alcohol benzylicus
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
citralum
- Substance HBESI
citronellolum
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
silica colloidalis anhydrica
- Substance HNIDK
limonis aetheroleum
- Substance HNIDK

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
55737
Drug name
Nasobol Inhalo, Brausetabletten zur Herstellung eines Dampfs zur Inhalation
Galenic form
BRTDI
ATC Code
R05X
Authorization status
Z
Dispensing category
D
First authorization
03/06/2003
Authorization expiration date
31/12/9999
IT Number
12.03.3.
Domain
Human medicine
Field of application
Atemwegserkrankungen

Package details

Description (FR)
NASOBOL Inhalo cpr eff 30 pce
Description (DE)
NASOBOL Inhalo Brausetabl 30 Stk
Market launch
03/06/2003
Narcotic (BTM)
No
Buy us a coffee Explore the data